BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4380550)

  • 1. Facilitation of ganglionic transmission by some adrenergic neurone blocking drugs.
    Farmer JB; Rand MJ; Wilson J
    Int J Neuropharmacol; 1966 May; 5(3):241-6. PubMed ID: 4380550
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological studies on guanethidine derivatives. V. Adrenergic neurone blocking action of 2,3,4,5-tetrahydro-1H-3-benzazepine-3-carboxamidine sulfate].
    Ozawa H; Otsuki I
    Yakugaku Zasshi; 1967 Nov; 87(11):1387-93. PubMed ID: 4385498
    [No Abstract]   [Full Text] [Related]  

  • 3. Adrenergic neurone blocking agents: tolerance and hypersensitivity to adrenaline and noradrenaline.
    Green AF; Robson RD
    Br J Pharmacol Chemother; 1965 Oct; 25(2):497-506. PubMed ID: 5866728
    [No Abstract]   [Full Text] [Related]  

  • 4. Resistance of mechanical and electrical responses to hypogastric nerve stimulation to alpha-blocking agents in guinea-pig vas deferens.
    Nakanishi H; Doteuchi M; Takeda H
    Jpn J Pharmacol; 1970 Mar; 20(1):61-70. PubMed ID: 4393816
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of bretylium and guanethidine: tolerance, and effects on adrenergic nerve function and responses to sympathomimetic amines.
    BOURA AL; GREEN AF
    Br J Pharmacol Chemother; 1962 Aug; 19(1):13-41. PubMed ID: 13871863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the central vasomotor effects of (-)-N-(1-phenylethyl)guanidine, a new adrenergic neuron blocking agent.
    Bapat SK; Dhawan BN; Srimal RC
    Can J Physiol Pharmacol; 1969 Aug; 47(8):725-9. PubMed ID: 5820115
    [No Abstract]   [Full Text] [Related]  

  • 7. Investigation of sympathetic activity resulting from a dose of acetylcholine producing a hypertensive response.
    Carter VL; Traber DL; Gardier RW
    J Pharmacol Exp Ther; 1967 May; 156(2):232-7. PubMed ID: 4381701
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacology of N-[2-(2,6-xylyloxy)ethyl]-guanidine sulphate; an adrenergic neurone blocking agent.
    Barron DI; Natoff IL; Vallance DK
    Br J Pharmacol Chemother; 1965 Oct; 25(2):534-44. PubMed ID: 5866731
    [No Abstract]   [Full Text] [Related]  

  • 9. Dual actions of some N-(1-phenylethyl)guanidines on the nictitating membrane of conscious cats.
    Fielden R
    J Pharm Pharmacol; 1967 Apr; 19(4):217-20. PubMed ID: 4382304
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the pharmacology of quaternary derivatives of beta-phenylethylamine].
    Holtz P; Menkens K; Palm D
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(2):193-220. PubMed ID: 4385671
    [No Abstract]   [Full Text] [Related]  

  • 11. The relationship between adrenergic neurone blocking activity and local anaesthetic activity in a series of guanidine derivatives.
    Rand MJ; Wilson J
    Eur J Pharmacol; 1967 May; 1(3):200-9. PubMed ID: 6069945
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of sympathomimetic amines on the blocking action of guanethidine, bretylium and xylocholine.
    DAY MD
    Br J Pharmacol Chemother; 1962 Apr; 18(2):421-39. PubMed ID: 13884064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacologic inhibition of the mobilization of free fatty acids].
    Bert F; Paoletti R
    Rev Atheroscler (Paris); 1968; 10(1):31-42. PubMed ID: 4386492
    [No Abstract]   [Full Text] [Related]  

  • 14. Sympathetic nervous system blocking agents. V. Derivatives of isobutyl-, t-butyl-, and neopentylguanidine.
    Short JH; Ours CW; Ranus WJ
    J Med Chem; 1968 Nov; 11(6):1129-35. PubMed ID: 5680024
    [No Abstract]   [Full Text] [Related]  

  • 15. The actions of bretylium: adrenergic neurone blocking and other effects.
    BOURA AL; GREEN AF
    Br J Pharmacol Chemother; 1959 Dec; 14(4):536-48. PubMed ID: 13803290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bethanidine on response to ergotamine and noradrenaline.
    Follenfant M; Green AF
    Br J Pharmacol; 1970 May; 39(1):225P-226P. PubMed ID: 4392964
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the mechanism of action of new drugs effective upon the autonomic and central nervous system].
    Oberdorf A; Hoffmeister F; Kroneberg G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):48-9. PubMed ID: 4231861
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological actions of phosphocholine 2,6-xylyl ether bromide (phospho-TM10; PTM10).
    Hughes IE
    J Pharm Pharmacol; 1970 Jun; 22(6):433-40. PubMed ID: 4396106
    [No Abstract]   [Full Text] [Related]  

  • 19. Protection against traumatic shock by guanethidine, bretylium and betaTM 10.
    LUM BK; CALVERT DN
    J Pharmacol Exp Ther; 1962 Oct; 138():74-7. PubMed ID: 13931638
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of adrenergic function in the treatment of hypertension.
    Frohlich ED
    Arch Intern Med; 1974 Jun; 133(6):1033-48. PubMed ID: 4151442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.